BAT bid for Imasco faces lawsuit
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A CLASS ACTION lawsuit has been filed to block British American Tobacco's C$10.3bn (pounds 4.4bn) bid for the tobacco, financial services and drugstore conglomerate Imasco. In a claim filed in the Superior Court, Ontario, on Thursday against London-based BAT and Imasco of Montreal, plaintiff Daniel Stern seeks an injunction against proceeding with the offer, arguing that it is inadequate at C$40 a share.
The suit, filed on behalf of a class of plaintiffs, also claims damages of C$1.26bn. Don Lebans, a lawyer representing the plaintiff, said the award was based on the difference between BAT's offer and the amount that analysts suggest the company is worth. Imasco said it would vigorously defend itself against the lawsuit, which it described as having "no merit" and containing "manifest errors". The group said that its board was committed to "obtaining the best achievable price for the Imasco public shareholders".
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments